Limited ability to activate protein C confers left atrial endocardium a thrombogenic phenotype: a role in

Jorge Cerveró1, Ramón Montes, Francisco España

  • 1Division of Cardiovascular Sciences, Centre for Applied Medical Research, University of Navarra, Avenida Pío XII, 55, 31008 Pamplona, Spain.

Stroke
|June 25, 2011
PubMed

Insights

Left atrial tissue shows impaired protein C activation due to lower thrombomodulin expression, increasing cardioembolic stroke risk. This finding helps explain why thrombi form in the left atrium during atrial fibrillation.

Area of Science:

  • Cardiovascular Research
  • Hemostasis and Thrombosis
  • Biomedical Science

Background:

  • Atrial fibrillation is a primary risk factor for cardioembolic stroke.
  • Thrombus formation predominantly occurs in the left atrial appendage, but the underlying reasons are unclear.
  • Understanding differential thrombogenicity between atrial chambers is crucial for stroke prevention.

Purpose of the Study:

  • To compare protein C activation capacity between the right and left atria.
  • To investigate the expression levels of thrombomodulin and endothelial protein C receptor in the endocardium of both atria.
  • To elucidate the mechanisms behind the higher thrombogenicity of the left atrial appendage.

Main Methods:

  • Ex vivo assessment of protein C activation in atrial tissues from 6 non-human primates (Macaca fascicularis).
  • Immunofluorescence staining to quantify thrombomodulin and endothelial protein C receptor expression on the endocardium.
  • Comparative analysis of protein C activation and receptor expression between right and left atria.

Main Results:

  • Protein C activation capacity was significantly reduced by half in the left atrium compared to the right atrium (P=0.028).
  • Thrombomodulin expression was significantly lower in the left atrial endocardium (52.5±19.9 AU) than in the right atrial endocardium (72.1±18.8 AU) (P=0.028).
  • No significant difference was observed in the expression of endothelial protein C receptor between the two atria.

Conclusions:

  • Reduced protein C activation in the left atrium, linked to diminished thrombomodulin expression, may underlie its increased thrombogenicity.
  • These findings offer a potential explanation for the higher incidence of thrombus formation in the left atrial appendage.
  • This research contributes to understanding the pathophysiology of cardioembolic stroke in atrial fibrillation.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...